113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III

Circulating endothelial extracellular vesicles from sickle cell patients promote susceptibility of pulmonary endothelium to thrombotic injury

Sickling kinetics drive genotype specific impairment of RBC deformability in sickle cell disease

IHP 102 reduces pain and modulates complement activation in a sickle cell mouse model

IHP 102 compound decreases the adhesion of sickle cell disease RBCs to acutely activated endothelial cells in biochip labs endothelial on a chip assay

Mechanisms of acute pain involve spinal IL17 TNF α IL 6–p38 MAPK activation in sickle cell disease

Machine Learning–Guided identification of survival associated genetic variants in sickle cell disease

Impact of G6PD Α mutation on hemoglobin function and RBC rheology in sickle cell disease

Caspase 4 11 alters circulating immune cells and mediates organ damage in Townes SCD mice

Defining therapeutic chimerism thresholds for comprehensive sickle cell disease correction in the townes mouse model